Phase I, Open-label Trial in Healthy Subjects to Evaluate the Drug-drug Interaction Between Ritonavir at Steady-state and TMC435350, a Viral Protease Inhibitor Against Hepatitis C Virus, After the First and the Last Dose of a Multiple Dosing Regimen
Latest Information Update: 03 Oct 2021
At a glance
- Drugs Simeprevir (Primary) ; Ritonavir
- Indications Hepatitis C
- Focus Pharmacokinetics
- 05 Jul 2013 New trial record